ACGL vs GBLI
ACGL: A diversified global insurer and reinsurer providing comprehensive risk solutions across insurance, reinsurance, and mortgage markets. GBLI: A specialty insurance provider operating in the excess and surplus lines market with a focus on underwriting profitability and disciplined capital management.
Side-by-side fundamentals
| Metric | ACGL | GBLI | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | $100.28 | $24.00 | |
| Market cap | $34.2B | $370M | |
| P/E as of 2026-10-21 | 7.85 | 10.13 | ACGL lower |
| Net margin FY2025, SEC XBRL | +22.1% | +5.6% | ACGL higher |
| ROE FY2025, SEC XBRL | +18.2% | +3.6% | ACGL higher |
| ROA FY2025, SEC XBRL | +5.6% | +1.5% | ACGL higher |
| Revenue growth (YoY) FY2025, SEC XBRL | +14.3% | +2.0% | ACGL higher |
| Revenue CAGR (3y) SEC XBRL | +27.5% | -10.5% | ACGL higher |
| Dividend yield as of 2026-09-03 | n/a | +5.4% | |
| Dividend streak (yrs) SEC XBRL | 2 | 8 | GBLI higher |
| Beta as of 2026-09-03 | 0.30 | 0.16 | |
| 1-year return as of 2026-10-21 close | +14.3% | -17.4% | ACGL higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.